Nanostring Tech (NSTG) Tops Q2 EPS by 7c; Receives Approval in Australia for Prosigna Assay

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Nanostring Tech (NSTG) Tops Q2 EPS by 7c; Receives Approval in Australia for Prosigna Assay

NanoString Technologies Releases Financial Results for Second Quarter of 2014

August 5, 2014 4:01 PM EDT

- Strong Q2 2014 Revenue Growth of 51% Year over Year - - Initiation of First Companion Diagnostic Collaboration with Celgene Corporation -

SEATTLE, Aug. 5, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the quarter ended June 30, 2014.

Financial Highlights:

Record total revenue of $10.9 million, 51% year-over-year growth Instrument revenue of $3.8 million, 49% year-over-year growth Cumulative installed base of approximately 220 nCounter® Analysis Systems and 500 publications Record... More